Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10

被引:106
作者
Raftery, MJ
Wieland, D
Gronewald, S
Kraus, AA
Giese, T
Schönrich, G
机构
[1] Humboldt Univ, Charite, Sch Med, Inst Virol, Berlin, Germany
[2] Heidelberg Univ, Inst Immunol, Heidelberg, Germany
关键词
D O I
10.4049/jimmunol.173.5.3383
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human dendritic cells (DCs) are essential for the antiviral immune response and represent a strategically important target for immune evasion of viruses, including human CMV (HCMV). Recently, HCMV has been discovered to encode a unique IL-10 homologue (cmvIL-10). In this study we investigated the capacity of cmvIL-10 to shape phenotype, function, and survival of DCs. For comparison we included human IL-10 and another IL-10 homologue encoded by EBV, which does not directly target DCs. Interestingly, cmvIL-10 strongly activated STAT3 in immature DCs despite its low sequence identity with human IL-10. For most molecules cmvIL-10 blocked LPS-induced surface up-regulation, confirming its role as an inhibitor of maturation. However, a small number of molecules on LPS-treated DCs including IDO, a proposed tolerogenic molecule, showed a different behavior and were up-regulated in response to cmvIL-10. Intriguingly, the expression of C-type lectin DC-specific ICAM-grabbing nonintegrin, a receptor for HCMV infection found exclusively on DCs, was also enhanced by cmvIL-10. This phenotypic change was mirrored by the efficiency of HCMV infection. Moreover, DCs stimulated with LPS and simultaneously treated with cmvIL-10 retained the function of immature DCs. Finally, cmvIL-10 increased apoptosis associated with DC maturation by blocking up-regulation of the antiapoptotic long form cellular FLIP. Taken together, these findings show potential mechanisms by which cmvIL-10 could assist HCMV to infect DCs and to impair DC function and survival.
引用
收藏
页码:3383 / 3391
页数:9
相关论文
共 61 条
[11]   The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling [J].
Dustin, ML ;
Cooper, JA .
NATURE IMMUNOLOGY, 2000, 1 (01) :23-29
[12]   Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytes [J].
Engering, A ;
van Vliet, SJ ;
Geijtenbeek, TBH ;
van Kooyk, Y .
BLOOD, 2002, 100 (05) :1780-1786
[13]  
ESOUSA CR, 2001, IMMUNITY, V14, P495
[14]   A homolog of interleukin-10 is encoded by the poxvirus orf virus [J].
Fleming, SB ;
McCaughan, CA ;
Andrews, AE ;
Nash, AD ;
Mercer, AA .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4857-4861
[15]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[16]   L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus [J].
Gardner, JP ;
Durso, RJ ;
Arrigale, RR ;
Donovan, GP ;
Maddon, PJ ;
Dragic, T ;
Olson, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4498-4503
[17]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[18]   Dendritic cells:: multi-lineal and multi-functional [J].
Grabbe, S ;
Kämpgen, E ;
Schuler, G .
IMMUNOLOGY TODAY, 2000, 21 (09) :431-433
[19]   Inducible IL-2 production by dendritic cells revealed by global gene expression analysis [J].
Granucci, F ;
Vizzardelli, C ;
Pavelka, N ;
Feau, S ;
Persico, M ;
Virzi, E ;
Rescigno, M ;
Moro, G ;
Ricciardi-Castagnoli, P .
NATURE IMMUNOLOGY, 2001, 2 (09) :882-888
[20]  
Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO